Phase I/ II Trial of Carboplatin and Etoposide Plus LBH589 for Previously Untreated Extensive Stage Small Cell Lung Cancer.

Trial Profile

Phase I/ II Trial of Carboplatin and Etoposide Plus LBH589 for Previously Untreated Extensive Stage Small Cell Lung Cancer.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Panobinostat (Primary) ; Carboplatin; Etoposide
  • Indications Adenocarcinoma; Lung cancer; Neuroendocrine carcinoma; Non-small cell lung cancer; Small cell lung cancer; Squamous cell cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Aug 2011 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 25 May 2011 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 01 Mar 2011 Recruitment completed, according to results published in the Anticancer Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top